All In Biotech

Drug Trial Radar · NCT00497146

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

The PRIMO Study: Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

Last checked: Nov 19, 2026Latest source record: Mar 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 227 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

227

Actual

Start

Feb 2008

Primary completion

Sep 2010

Study completion Mar 2012

Sponsor

Lead sponsor
AbbVie (prior sponsor, Abbott)AbbVie (ABBV)
Sponsor type
Industry
Collaborators
Massachusetts General Hospital
First posted
Jul 6, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the effects of paricalcitol capsules on cardiac structure and function over 48 weeks in patients with Stage 3/4 chronic kidney disease (CKD) who had left ventricular hypertrophy (LVH).

Conditions

  • Chronic Kidney Disease
  • Left Ventricular Hypertrophy

Interventions

  • paricalcitolDrug

    2 µg capsule

  • placeboDrug

    placebo capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Left Ventricular Mass Index (LVMI) Over 48 Weeks Measured by Cardiac Magnetic Resonance Imaging (MRI)Time frame: Baseline to 48 weeks

Locations

71 sites in 12 countries. Site status is shown where the registry gives one.

  • Site Reference ID/Investigator# 8062

    Phoenix, Arizona

  • Site Reference ID/Investigator# 8867

    Tempe, Arizona

  • Site Reference ID/Investigator# 8864

    San Diego, California

  • Site Reference ID/Investigator# 7257

    San Dimas, California

  • Site Reference ID/Investigator# 7727

    Denver, Colorado

  • Site Reference ID/Investigator# 8861

    Miami, Florida

  • Site Reference ID/Investigator# 7260

    Orlando, Florida

  • Site Reference ID/Investigator# 7725

    Tampa, Florida

  • Site Reference ID/Investigator# 7824

    Tampa, Florida

  • Site Reference ID/Investigator# 18882

    Meridian, Idaho

  • Site Reference ID/Investigator# 7823

    Chicago, Illinois

  • Site Reference ID/Investigator# 7249

    Evergreen Park, Illinois

  • Site Reference ID/Investigator# 7816

    Bethesda, Maryland

  • Site Reference ID/Investigator# 18881

    Rockville, Maryland

  • Site Reference ID/Investigator# 7817

    Springfield, Massachusetts

  • Site Reference ID/Investigator# 7245

    Detroit, Michigan

  • Site Reference ID/Investigator# 7248

    Royal Oak, Michigan

  • Site Reference ID/Investigator# 8868

    Kansas City, Missouri

  • Site Reference ID/Investigator# 7828

    St Louis, Missouri

  • Site Reference ID/Investigator# 14442

    Omaha, Nebraska

  • Site Reference ID/Investigator# 6567

    Winston-Salem, North Carolina

  • Site Reference ID/Investigator# 7262

    Winston-Salem, North Carolina

  • Site Reference ID/Investigator# 7826

    Allentown, Pennsylvania

  • Site Reference ID/Investigator# 8865

    Chattanooga, Tennessee

  • Site Reference ID/Investigator# 7261

    Houston, Texas

  • Site Reference ID/Investigator# 8058

    Houston, Texas

  • Site Reference ID/Investigator# 7830

    San Antonio, Texas

  • Site Reference ID/Investigator# 7825

    Murray, Utah

  • Site Reference ID/Investigator# 8866

    Provo, Utah

  • Site Reference ID/Investigator# 7263

    Fairfax, Virginia

  • Site Reference ID/Investigator# 8493

    Adelaide, Australia

  • Site Reference ID/Investigator# 8506

    Liverpool, Australia

  • Site Reference ID/Investigator# 8507

    Parkville, Australia

  • Site Reference ID/Investigator# 9581

    Reservoir, Australia

  • Site Reference ID/Investigator# 9582

    Richmond, Australia

  • Site Reference ID/Investigator# 8500

    Westmead, Australia

  • Site Reference ID/Investigator# 8245

    Prague, Czechia

  • Site Reference ID/Investigator# 8246

    Prague, Czechia

  • Site Reference ID/Investigator# 8499

    Prague, Czechia

  • Site Reference ID/Investigator# 6692

    Dortmund, Germany

Showing 40 of 71 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.